| Document Date: 2013-09-26 11:12:16 Open Document File Size: 3,29 MBShare Result on Facebook
Company TIGENIX / / Continent Europe / / Country Japan / South Korea / United States / / Currency EUR / / Event FDA Phase / / Facility clinic Research / / IndustryTerm perspectives healthcare sciencesEuropean / healthcare sciences / healthcare systems / treatment for patients suffering from the rare disease / / MedicalCondition osteoarthritis / disease / Alpha mannosidosis / rare disease / breast cancer / / Organization largest multi-national fund / European Union / World Congress / / Position Innovation Irene Norstedt Head of Personalised Medicine Unit / / Product EU / / Technology Alpha / CVD / drug development / human genome / /
SocialTag |